Coloplast (COLO) AGM 2021 summary
Event summary combining transcript, slides, and related documents.
AGM 2021 summary
23 Oct, 2026Financial performance review
The annual report for FY 2020/21 was approved.
Board and executive committee updates
Lars Søren Rasmussen, Niels Peter Louis-Hansen, Carsten Hellmann, Jette Nygaard-Andersen and Marianne Wiinholt were re-elected; Annette Brüls was elected as a new Board member.
After the AGM, Lars Søren Rasmussen was elected Chairman and Niels Peter Louis-Hansen Deputy Chairman; employee-elected members are Thomas Barfod, Nikolaj Kyhe Gundersen and Roland Vendelbo Pedersen.
Dividend announcements
A year-end dividend of DKK 14.00 per nominal DKK 1 share was approved; with the interim DKK 5.00 dividend, total FY 2020/21 distributions were DKK 19.00 per share.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Coloplast
- AGM approves DKK 9.00 dividend and governance changes.COLO
AGM 2016 - AGM approves DKK 11 dividend, share-issuance changes and new Board member.COLOAGM 2018
- AGM approved a DKK 17.00 per-share dividend and governance changes alongside Board re-elections.COLOAGM 2019
- FY 2021/22 AGM approved DKK 20 per share in dividends and re-elected the Board.COLOAGM 2022
- Strong organic growth and margin resilience driven by innovation and operational efficiency.COLOInvestor presentation
- 6% organic growth and strong cash flow, but Biologics hit by US reforms and Kerecis impairment.COLOQ3 25/26
- AGM approved a DKK 23.00 per-share dividend and elected Niels B. Christiansen to the Board.COLOAGM 2025
- 8% organic growth, a DKK 22 dividend, and four-platform strategy highlighted the AGM.COLOAGM 2024
- 8% organic growth and 27% EBIT margin before special items, FY guidance unchanged.COLOQ1 24/25